4
Changes in Ownership
HALOZYME THERAPEUTICS, INC. Filed Acc 0001415889-25-004243
Options or other derivatives
- SVP, CHIEF TECHNICAL OFFICER acquired 36,702 shares (grant or award)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Derivatives | |||||||
| LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | 2025-02-12 | Grant or award · Performance Stock Units | +7,262 | 20,891 | D | ||
| LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | 2025-02-12 | Grant or award · Performance Stock Units | +4,177 | 6,547 | D | ||
| LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | 2025-02-12 | Grant or award · Performance Stock Unit | +4,921 | 4,921 | D | ||
| LaBarre Michael J. SVP, CHIEF TECHNICAL OFFICER | 2025-02-12 | Grant or award · Performance Stock Units | +20,342 | 20,342 | D | ||
Loading xslF345X05/form4-02142025_110258.xml…